Grant - Epizyme
Investment Firm
Overview
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
Announced Date
Jan 06, 2011
Funding Type
Grant
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Epizyme raised $1000000 on 2011-01-06 in Grant
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
Company Funding History
15
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 14, 2011 |  Venture Round - Epizyme | 1 | - | 4.0M |
| Jun 23, 2011 | Venture Round - Epizyme | 1 | - | 7.5M |
| Dec 08, 2009 | Series B - Epizyme | 1 | - | 8.0M |
| Oct 07, 2009 | Series B - Epizyme | 5 | - | 32.0M |
Recent Activity
There is no recent news or activity for this profile.